Inaktiver Wert

Andere Sprachen Hercules Technology Growth Capital Inc Nasdaq

Aktien

US4270965084

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Cybersecurity firm Semperis raises $125 mln from JP Morgan, Hercules Capital	18:17
Hercules Capital : 2025 Proxy Statement	17.05.
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital	15.05.
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders	13.05.
Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC completed the acquisition of ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others.	13.05.
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS	10.05.
Electric Hydrogen secures $100M credit facility from HSBC, J.P. Morgan, Stifel Bank and Hercules Capital to decarbonize critical industries at scale	10.05.
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise	09.05.
Verona Pharma Signs Financing Agreements for Up to $650 Million	09.05.
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility	09.05.
Hercules Capital Announces Upcoming Event for the Financial Community	07.05.
Hercules Capital: Q1 Earnings Snapshot	02.05.
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02.05.
Hercules Capital Reports First Quarter 2024 Financial Results	02.05.
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024	30.04.
Hercules Capital, Inc. Declares First Quarter Cash Dividend, Payable on May 14, 2024	30.04.
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment	30.04.
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations	24.04.
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call	18.04.
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.	03.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hercules Technology Growth Capital Inc Nasdaq

Aktien

US4270965084

Andere Sprachen

Filter